Generic placeholder image

Current Women`s Health Reviews


ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Research Article

Prevalence of Latent Tuberculosis (LTB) Among Pregnant Women in a High Burden Setting in Sudan using Interferon Gamma (IFN- γ) Releasing Assay (IGRA)

Author(s): Khalid Yassin, Elbashir G.E. Ahmed, Abdualmoniem O. Musa, Hamdan Z. Hamdan, Nadir Abuzied, Asma A. Fagear, Gamal K. Adam, Tajeldin M. Abdalla and AbdelAziem A. Ali*

Volume 15, Issue 3, 2019

Page: [214 - 217] Pages: 4

DOI: 10.2174/1573404814666180906125843

Price: $65


Background: Accurate timing for diagnosis and treatment of latent tuberculosis (LTB) is important to reduce morbidity and mortality for both mother and child.

Objectives: To investigate the prevalence rate of LTB and its associated factors during pregnancy using gamma interferon (IFN- γ) release assay (IGRA).

Methods: A cross-sectional facility-based study carried out in Kassala hospital, Eastern Sudan between January and March 2015.

Results: Two hundred and forty-nine women were enrolled in this study and 18.1% (45/249) had confirmed positive for M. tuberculosis infection using IGRA. The mean age, parity and gestational age of the LTB patients were 29.6 (4.4), 2.2 (1.2) and 21.9 (8.8), respectively. The vast majority of these patients was of rural residence (72.7%), housewives (91.1%) and illiterate (73.3%). More than half (25, 55.6%) gave a history of contact with tuberculosis patients, 26.7% (12/45) were vaccinated and 11.1% (5/45) had a medical history of diabetes mellitus. In logistic regression model, while age, parity, education, occupation, size of family members, smoking, BCG status and medical history of diabetes mellitus were not associated with latent tuberculosis during pregnancy, history of contact with TB patients (OR=13.5; CI=5.6 to 32.5; P<0.001) and rural residence (OR=0.3; CI=0.1 to 0.7; P=0.006) was significantly correlated to LTB in pregnancy.

Conclusion: Thus, screening of all pregnant women living in high burden setting of tuberculosis is recommended even in the absence of overt clinical signs of the disease.

Keywords: Tuberculosis, pregnancy, gamma interferon, infection, sudan, diabetes mellitus.

Graphical Abstract
World Health Organization (2009) "Epidemiology". Global tuberculosis control: epidemiology, strategy, financing. Pp. 6-33. ISBN 978 92 4 156380.. report/2009/pdf/chapter1.pdf [Accessed on: November 12, 2009].
Centres for Disease Control Prevention (CDC). Trends in Tuberculosis-United States, 2005. MMWR 2006; 55(11): 305-8.
World Health Organization. Global tuberculosis control: WHO report 2013. WHO, Geneva, Switzerland..
Onyebujoh P, Rook GAW. World Health Organization Watch: Focus: Tuberculosis. December 2004. [Accessed on: October 7, 2006].
The Global Plan to Stop Tb 2011-2015: Transforming the Fight Towards Elimination of Tuberculosis, World Health Organization, Geneva, Switzerland, 2010.
Stop TB. Partnership. London tuberculosis rates now at Third World Proportions. PR Newswire Europe Ltd. 4 December 2002. Retrieved on: October 3, 2006.
Khilnani GC. Tuberculosis and pregnancy. Indian J Chest Dis Allied Sci 2004; 46: 105-11.
Abdallah TM, Ali AA. Epidemiology of tuberculosis in Eastern Sudan. Asian Pac J Trop Biomed 2012; 2(12): 999-1001.
Ali AA, Abdallah TM, Rayis DA, Adam I. Maternal and perinatal outcomes of pregnancies asociated with tuberculosis in eastern Sudan. Int J Gynaecol Obstet 2011; 114: 286-7.
Metcalfe JZ, Everett CK, Steingart KR, et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: Systematic review and meta-analysis. J Infect Dis 2011; 204(Suppl. 4): S1120-9.
Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 2014; 27(1): 3-20.
Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers http://www.
Nhan-Chang CL, Jones TB. Tuberculosis in pregnancy. Clin Obstet Gynecol 2010; 53: 311-21.
Llewelyn M, Cropley I, Wilkinson RJ, Davidson RN. Tuberculosis diagnosed during pregnancy: A prospective study from London. Thorax 2000; 55: 129-32.
Cheng VC, Woo PC, Lau SK, et al. Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 2003; 22: 313-7.
Jonnalagadda S, Payne BL, Brown E, et al. Latent tuberculosis detection by interferon (gamma) release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 2010; 202: 1826-35.
Worjoloh A, Kato-Maeda M, Osmond D, Freyre R, Aziz N, Cohan D. Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy. Obstet Gynecol 2011; 118: 1363-70.
Landry J, Menzies D. Preventive chemotherapy. Where has it got us? Where to go next? Int J Tuberc Lung Dis 2008; 12: 1352-64.
Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med 2008; 177: 348-55.
Blum RN, Polish LB, Tapy JM, Catlin BJ, Cohn DL. Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status. Chest 1993; 103: 1670-4.
Mathad JS, Sambarey P, Bharadwaj R, et al. Screening for latent tuberculosisin pregnant women: A comparison of an interferon-γ release assay with tuberculin skin testing in Pune, India. In: Programs and abstracts of the 49th Infectious Diseases Society of America, Boston, MA, 2011; Abstract no. 313362011
Ali AA, Adam I. Lack of antenatal care, education, and high maternal mortality in Kassala hospital, eastern Sudan during 2005-2009. J Matern Fetal Neonatal Med 2011; 24(8): 1077-8.
Figueroa-Damian R, Redondo-Garcia JL. Pregnancy and tuberculosis: Influence of treatment on perinatal outcome. Am J Perinatol 1998; 15: 303-6.
Palacios E, Dallman R, Muñoz M. Drug-resistant tuberculosis and pregnancy: Treatment outcomes of 38 cases in Lima, Peru. Clin Infect Dis 2009; 48: 1413-9.
Declaration of Helsinki. World Medical Association. Available from [Accessed on: June 24, 2008].

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy